GAP Gap Inc Q1 2026 EPS narrowly misses analyst estimates sending shares 087 percent lower in todays trade ALT Altimmune posts 105 revenue growth but misses Q4 earnings estimates by 102 sparking 675 stock decline BKSY BlackSky reports far narrower Q4 2025 loss versus analyst estimates shares tick slightly higher today Gilead Sciences GILD Pipeline Milestones and Arcellx Acquisition Reinforce LongTerm Growth Trajectory in HIV and Oncology Forrester Research FORR Q1 2026 Disappoints EPS 004 Below 012 Views The Joint JYNT Holds 820 Direction Awaited 20260515 Wall Streets New Source of Anxiety The Surge in Bond Yields UK Aviation Watchdog Weighs New Rules for Heathrow Expansion Potential Rival Airport Could Lead Growth